Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

Presentation TCT 2024

Overview of Clinical Data on TAVR in BAVD – Is an RCT Needed?

Presenter: Yousif Ahmad

October 30, 2024

Presentation NY Valves 2024

Aortic Valve Replacement in BAV: Biprosthesis for Everyone? When to Consider TAVR? Do We Need Thoughtful RCTs?

Presenter: Raj Makkar

June 06, 2024

Presentation NY Valves 2024

Considerations for Designing a TMVR vs. TEER RCT

Presenter: Pradeep K. Yadav

June 05, 2024

Presentation TCT 2023

We Need an RCT, and Here Is How I Would Like to Design It

Presenter: David Cohen

October 24, 2023

Presentation TCT 2022

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Presenter: Scott Lim

September 18, 2022

Presentation TCT 2022

A Deeper Dive Into the CLASP Technology and IID RCT Results

Presenter: Scott Lim

September 17, 2022

Presentation TVT 2022

TEER vs. TMVR for FMR - Time for RCT?

Presenter: Gorav Ailawadi

June 10, 2022

Presentation TCT Abstracts Posters 2019

Transcatheter Aortic Valve Replacement in Low-risk Patients A Meta-analysis of Randomized Controlled Trials

Presenter: Ahmad Al-Abdouh

October 06, 2019

Presentation TCT 2019

Remaining Data Gaps After the Low-Risk TAVR RCTs

Presenter: Michael Borger

September 26, 2019

Presentation TVT 2019

TENDYNE: Attributes, Challenges, and Clinical Data (SUMMIT)

Presenter: Gorav Ailawadi

June 14, 2019

Presentation TVT 2019

INTREPID: Attributes, Challenges, and Clinical Data (APOLLO)

Presenter: Martin Leon

June 14, 2019

Presentation TVT 2019

Reactions From the Surgical Community

Presenter: Patrick McCarthy

June 13, 2019

Presentation TVT 2019

Reactions From the Cardiology Community

Presenter: Blase Carabello

June 13, 2019

Presentation TVT 2019

Highlights From the CoreValve Low-Risk Trial

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

Highlights From the PARTNER 3 Low-Risk Trial

Presenter: Michael Mack

June 13, 2019

Presentation CIT 2019

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Presenter: Yaling Han

March 28, 2019

Presentation TCT 2018

Updated RCT Data for PFO Closure in All-Comers and Subgroups With Cryptogenic Stroke: How Should the Guidelines Be Updated?

Presenter: Teiji Akagi, John D. Carroll, Konstantinos Dean Boudoulas

September 22, 2018

Presentation The Structural Heart Disease Summit 2018

The TENDYNE Program: Attributes, Challenges, and Clinical Data (FDA Pivotal RCT)

Presenter: Rashmi Yadav

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The INTREPID Program: Attributes, Challenges, and Clinical Data (FDA Pivotal RCT APOLLO)

Presenter: Vinayak Bapat

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Neochord Forges Ahead: Technology and Clinical Updates (FDA Pivotal RCT)

Presenter: Andrea Colli

June 21, 2018

Advertisement

Overview of Clinical Data on TAVR in BAVD – Is an RCT Needed?

Aortic Valve Replacement in BAV: Biprosthesis for Everyone? When to Consider TAVR? Do We Need Thoughtful RCTs?

Considerations for Designing a TMVR vs. TEER RCT

We Need an RCT, and Here Is How I Would Like to Design It

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

A Deeper Dive Into the CLASP Technology and IID RCT Results

TEER vs. TMVR for FMR - Time for RCT?

Transcatheter Aortic Valve Replacement in Low-risk Patients A Meta-analysis of Randomized Controlled Trials

Remaining Data Gaps After the Low-Risk TAVR RCTs

TENDYNE: Attributes, Challenges, and Clinical Data (SUMMIT)

INTREPID: Attributes, Challenges, and Clinical Data (APOLLO)

Reactions From the Surgical Community

Reactions From the Cardiology Community

Highlights From the CoreValve Low-Risk Trial

Highlights From the PARTNER 3 Low-Risk Trial

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Updated RCT Data for PFO Closure in All-Comers and Subgroups With Cryptogenic Stroke: How Should the Guidelines Be Updated?

The TENDYNE Program: Attributes, Challenges, and Clinical Data (FDA Pivotal RCT)

The INTREPID Program: Attributes, Challenges, and Clinical Data (FDA Pivotal RCT APOLLO)

Neochord Forges Ahead: Technology and Clinical Updates (FDA Pivotal RCT)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content